NCT02023606

Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M

An Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion (AME) of [14C] Labeled SPN-810M in Healthy Adult Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 7 (actual)
• Sponsor: Supernus Pharmaceuticals, Inc. · Industry
• Sex: Male
• Age: 30 Years – 55 Years
• Healthy volunteers: Accepted

Summary

An Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion of Radio Labeled SPN-810M in Healthy Adult Male Volunteers

Conditions

• Impulsive Aggression Comorbid With ADHD

Interventions

Type	Name	Description
DRUG	SPN-810M

Timeline

• Start date: 2013-11-01
• Primary completion: 2013-12-01
• Completion: 2013-12-01
• First posted: 2013-12-30
• Last updated: 2016-05-13

Locations

1 site across 1 country: United Kingdom